Download
s12876-020-01427-4.pdf 1,09MB
WeightNameValue
1000 Titel
  • HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level
1000 Autor/in
  1. Willuweit, Katharina |
  2. Frey, Alexandra |
  3. Bieniek, Lisa |
  4. Heinold, Andreas |
  5. Büchter, Matthias |
  6. Horn, Peter A. |
  7. Wedemeyer, Heiner |
  8. Herzer, Kerstin |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-27
1000 Erschienen in
1000 Quellenangabe
  • 20(1):288
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12876-020-01427-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457295/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!The importance of donor-specific antibodies (DSA) after liver transplantation (LT) for graft and patient survival is an ongoing controversy. So far it has not been elucidated when and in how far DSA are harmful for graft and patient survival. Therefore, we had the aim to investigate the association of DSA with complications after LT.!##!Methods!#!Data of 430 LT recipients were collected and statistically analyzed. Detection of HLA antibodies (Ab) was performed by Luminex assay.!##!Results!#!DSA were detected in 81 patients (18.8%). These were mainly HLA class II Ab (81.5%). HLA class II Ab show a higher MFI (median: 5.300) compared to HLA class I Ab (median: 2.300). There is no association between MFI levels and development of complications after LT. However, cirrhosis occurred significantly more often in DSA positive patients (18%) than in patients without detectable DSA (9%, P = 0.027). All DSA positive patients with cirrhosis of the graft showed HLA class II antibodies (OR: 3.028; 95% CI: 1.51-6.075; P = 0.002).!##!Conclusion!#!Occurrence of HLA class II DSA after LT is associated with graft cirrhosis and may indicate a higher risk to develop graft damage independent on MFI and requires an individualized risk management.
1000 Sacherschließung
lokal Graft Rejection [MeSH]
lokal Hepatobiliary and pancreatic disorders
lokal Humans [MeSH]
lokal HLA-antibody
lokal Liver Transplantation [MeSH]
lokal Graft Survival [MeSH]
lokal Isoantibodies [MeSH]
lokal Liver Cirrhosis/surgery [MeSH]
lokal Complications
lokal Kidney Transplantation [MeSH]
lokal Donor specific antibodies
lokal HLA Antigens [MeSH]
lokal Livertransplant
lokal Histocompatibility Testing [MeSH]
lokal Research Article
lokal Liver cirrhosis
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-1474-7733|https://frl.publisso.de/adhoc/uri/RnJleSwgQWxleGFuZHJh|https://frl.publisso.de/adhoc/uri/QmllbmllaywgTGlzYQ==|https://frl.publisso.de/adhoc/uri/SGVpbm9sZCwgQW5kcmVhcw==|https://frl.publisso.de/adhoc/uri/QsO8Y2h0ZXIsIE1hdHRoaWFz|https://frl.publisso.de/adhoc/uri/SG9ybiwgUGV0ZXIgQS4=|https://frl.publisso.de/adhoc/uri/V2VkZW1leWVyLCBIZWluZXI=|https://frl.publisso.de/adhoc/uri/SGVyemVyLCBLZXJzdGlu
1000 Hinweis
  • DeepGreen-ID: db8b997493d64d7c92d3410861880ca0 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6464501.rdf
1000 Erstellt am 2023-11-16T04:39:50.257+0100
1000 Erstellt von 322
1000 beschreibt frl:6464501
1000 Zuletzt bearbeitet Fri Dec 01 00:04:46 CET 2023
1000 Objekt bearb. Fri Dec 01 00:04:46 CET 2023
1000 Vgl. frl:6464501
1000 Oai Id
  1. oai:frl.publisso.de:frl:6464501 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source